Duality Biotherapeutics, Inc. (09606.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.8x

Market Cap

HKD 11.77B

MomentumView details →

1D Return

−1.53%

YTD Return

−39.40%

RSI (14)

42.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.8x

Market Cap

HKD 11.77B

RSI (14)

42.5

MomentumView details →

1D Return

−1.53%

YTD Return

−39.40%

ProfitabilityView details →

Gross Margin

−27.75%

Net Margin

−170.82%

EBITDA Margin

−182.30%

ROE (TTM)

−99.16%

ROA (TTM)

−41.02%

Asset Turnover

0.24x

GrowthView details →

Revenue YoY

−61.86%

EPS YoY

+78.23%

FCF YoY

—

Revenue CAGR 3Y

+940.78%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−HKD 11.76

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

1.99x

Quick Ratio

1.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

842.13M

Net Income (TTM)

−1.44B

Op. CF (TTM)

−395.18M

Latest newsMore news →

Duality Biotherapeutics Inc's IPO on the STAR Market has been updated to 'under inquiry' by the Shanghai Stock Exchange.63d ago

Similar companies

HBM Holdings Limited02142.HK 诺唯赞688105.SH Mabwell-b02493.HK Corcept Therapeutics IncorporatedCORT Arrowhead Pharmaceuticals, Inc.ARWR Bio-Techne CorporationTECH Find similar companies →

Latest newsMore news →

Duality Biotherapeutics Inc's IPO on the STAR Market has been updated to 'under inquiry' by the Shanghai Stock Exchange.63d ago